Werbung
Werbung
CASI
CASI Pharmaceuticals, Inc. Ordinary Shares
1.08
USDGesponsert
+0.02
+1.88%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
1.09
+0.01
+0.92%
CASI Ergebnisberichte
Positives Überraschungsverhältnis
CASI übertreffen die 19 der letzten 36Schätzungen.
53%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.36
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-100.00%
/-46.27%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/--
CASI Pharmaceuticals, Inc. Ordinary Shares earnings per share and revenue
On 14. Nov. 2025, CASI reported earnings of -0.67 USD per share (EPS) for Q3 25, missing the estimate of -0.40 USD, resulting in a -64.22% surprise. Revenue reached 3.08 million, compared to an expected --, with a 0.00% difference. The market reacted with a -5.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an decrease of -46.27% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
What were CASI Pharmaceuticals, Inc. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CASI Pharmaceuticals, Inc. Ordinary Shares reported EPS of -$0.67, missing estimates by -64.22%, and revenue of $3.08M, 0% as expectations.
How did the market react to CASI Pharmaceuticals, Inc. Ordinary Shares's Q3 2025 earnings?
The stock price moved down -5.56%, changed from $1.26 before the earnings release to $1.19 the day after.
When is CASI Pharmaceuticals, Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for CASI Pharmaceuticals, Inc. Ordinary Shares's next earnings report?
Based on 3
analysts, CASI Pharmaceuticals, Inc. Ordinary Shares is expected to report EPS of -$0.36 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung